A Phase III Randomised Double blind Placebo controlled Multi centre International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced Unresectable Non Small Cell Lung Cancer Stage III Who Have Not Progressed Following Definitive Platinum based Concurrent Chemoradiation Therapy PACIFIC